This brand name is authorized in Hong Kong
The drug DAIGAKU contains a combination of these active pharmaceutical ingredients (APIs):
1
Aminocaproic acid
UNII U6F3787206 - AMINOCAPROIC ACID
|
Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity. |
2
Chlorphenamine
UNII V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
|
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
3
Naphazoline
UNII MZ1131787D - NAPHAZOLINE HYDROCHLORIDE
|
Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity. |
4
Zinc sulfate
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: HK | Department of Health Drug Office | Identifier(s): 42060 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.